108
Views
115
CrossRef citations to date
0
Altmetric
Original Research

LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194

, &
Pages 5377-5390 | Published online: 10 Nov 2017

References

  • FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
  • SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
  • PuvanenthiranSEssapenSSeddonAMModjtahediHImpact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugsInt J Oncol20164951825183827599579
  • DillmanROMcClayEFBarthNMDendritic versus tumor cell presentation of autologous tumor antigens for active specific immunotherapy in metastatic melanoma: impact on long-term survival by extent of disease at the time of treatmentCancer Biother Radiopharm201530518719426083950
  • MantiasmaldoneGMEdwardsRPVladAMTargeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapiesCancer Manag Res20113253821734812
  • WeiWBirrerMJSpleen tyrosine kinase confers paclitaxel resistance in ovarian cancerCancer Cell20152817926175410
  • TangYCheungBBAtmadibrataBThe regulatory role of long noncoding RNAs in cancerCancer Lett2017391121928111137
  • XiaHHuiKMMechanism of cancer drug resistance and the involvement of noncoding RNAsCurr Med Chem201421263029304124735364
  • ZhangJLiuJXuXLiLCurcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancerCancer Chemother Pharmacol201779347948728175963
  • LiLGuMYouBLong non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinomaCancer Sci201610791215122227311700
  • LiZZhaoLWangQOverexpression of long non-coding RNA HOTTIP increases chemoresistance of osteosarcoma cell by activating the Wnt/β-catenin pathwayAm J Transl Res2016852385239327347346
  • NiuYFengMHuangWLong non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2Mol Cancer2017161528069000
  • SunwooHDingerMEWiluszJEAmaralPPMattickJSSpectorDLMEN epsilon/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspecklesGenome Res200919334735919106332
  • YuXLiZZhengHChanMTWuWKNEAT1: a novel cancer-related long non-coding RNACell Prolif2017502
  • ChenZJZhangZXieBBZhangHYClinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancerEur Rev Med Pharmacol Sci201620163373337727608895
  • ChaiYLiuJZhangZLiuLHuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancerCancer Med2016571588159827075229
  • YoonJHAbdelmohsenKGorospeMFunctional interactions among microRNAs and long noncoding RNAsSemin Cell Dev Biol201434491424965208
  • NakamuraKSawadaKKinoseYHashimotoKMabuchiSKimuraTAbstract 4386: identification of microRNA which regulates paclitaxel resistance of ovarian cancer cells – a potential of miR-194 by attenuating paclitaxel resistance through the down-regulation of oncogene BMI-1Cancer Res201474Suppl 19 Abstract nr 4386
  • LiZHuSWangJMiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cellsGynecol Oncol2010119112513020624637
  • LuDShiHCWangZXGuXWZengYJMultidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinomaBrJ Biomed Sci2011682697421706917
  • PilyuginMIrminger-FingerILong non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAsInt J Biochem Cell Biol201454835637625008968
  • StordalBPavlakisNDaveyRA systematic review of platinum and taxane resistance from bench to clinic: an inverse relationshipCancer Treat Rev200733868870317881133
  • ChenQNWeiCCWangZXSunMLong non-coding RNAs in anti-cancer drug resistanceOncotarget2017811925193627713133
  • ZhangJZhaoBChenXWangZXuHHuangBSilence of long noncoding RNA NEAT1 inhibits malignant biological behaviors and chemotherapy resistance in gastric cancerPathol Oncol ResIn press2017
  • GaoCZhangJWangQRenCOverexpression of lncRNA NEAT1 mitigates multidrug resistance by inhibiting ABCG2 in leukemiaOncol Lett20161221051105727446393
  • JiangPWuXWangXHuangWFengQNEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cellsOncotarget2016728433374335127270317
  • AndorferPRothenederHRegulation of the MDR1 promoter by E2F1 and EAPPFEBS Lett2013587101504150923542036
  • XingAYShiDBLiuWRestoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozymeExp Mol Pathol201394348148523531420
  • ZhangYZhouTDuanJXiaoZLiGXuFInhibition of P-glycoprotein and glutathione S-transferase-pi mediated resistance by fluoxetine in MCF-7/ADM cellsBiomed Pharmacother201367875776223731711
  • TayYRinnJPandolfiPPThe multilayered complexity of ceRNA crosstalk and competitionNature2014505748334435224429633
  • ZhuXLiDYuFmiR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 proteinOncotarget2016711131391315226909612
  • LiPYangYLiuHMiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1J Hematol Oncol20171013228122647
  • ZhangPSunYMaLZEB1: at the crossroads of epithelial–mesenchymal transition, metastasis and therapy resistanceCell Cycle201514448148725607528
  • ZouJLiuLWangQDownregulation of miR-429 contributes to the development of drug resistance in epithelial ovarian cancer by targeting ZEB1Am J Transl Res2017931357136828386361
  • LiPZhangXLinLChenGChenJSilencing of the long non-coding RNA NEAT1 suppresses ovarian cancer cell proliferation, migration and invasionInt J Clin Exp Pathol20169551385147